CUTIA-B (02487) announced that its Chief Executive Officer and Executive Director, Zhang Lele, has further increased his shareholding.

18/11/2024

Kedi-B (02487) issued an announcement, stating that the Board of Directors of the company received a notice from the company's Chief Executive Officer and Executive Director Zhang Lele...

CUTIA-B (02487) announced that the Board of Directors received a notification from the company's CEO and executive director, Zhang Lele, that he personally purchased a total of 5,200 shares of the company on the open market on November 14, 2024, at a total cost of approximately HK$49,600 (increase in shareholding).

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.

GREAT CHI HLDGS (00021): Wong Man Hei appointed as a new member of the nomination committee

Shandong Sito Bio-technology (300583.SZ): The chemical raw material drug budenide passed the drug GMP compliance inspection.

CH AGRI-PROD EX (00149) releases annual performance, with a net profit attributable to shareholders of 7.8 million Hong Kong dollars, an increase of 5.4% year-on-year.